Do Nanobubbles Improve Joint Hypoxia?
NCT04844008 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2022-05-24
Summary
Inflamed joints in patients with rheumatoid arthritis and psoriatic arthritis are characterized by low oxygen levels and inflammation. We propose to investigate whether tiny bubbles (nanobubbles) when given in a drink can alter oxygen level in joints. These nanobubbles are so small that they can enter the bloodstream when given as a drink. This information will give new information on the role of oxygen in joint inflammation and could possibly lead to new treatment approaches in the future.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Nanobubble drink
Commercially available sports drink
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-05
- Primary Completion
- 2022-05-17
- Completion
- 2022-05-17
Countries
- United Kingdom
Study Locations
More Related Trials
-
dnaJ Peptide for Relieving Rheumatoid Arthritis
NCT00000435 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)
NCT06222671 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis
NCT00548834 ·Status: COMPLETED ·Phase: PHASE3
-
Therapy of Niacin for Rheumatoid Arthritis
NCT07004725 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study in Patients With Rheumatoid Arthritis
NCT00966875 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Participants With Rheumatoid Arthritis
NCT01202773 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
NCT06276998 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
NCT02720120 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis
NCT03800797 ·Status: COMPLETED ·Phase: PHASE4
-
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
NCT01208207 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)
NCT00132769 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
NCT00717808 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
NCT00760864 ·Status: COMPLETED ·Phase: PHASE2
-
Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate
NCT02393378 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT02097264 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Rheumatoid Arthritis Study in Participants
NCT01202760 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis
NCT02896127 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis
NCT02429882 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)
NCT00928512 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
NCT04870203 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects
NCT00126724 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
NCT00113308 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis
NCT01749787 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs
NCT01209702 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects
NCT02705989 ·Status: COMPLETED ·Phase: PHASE1